120 related articles for article (PubMed ID: 2428770)
1. In vivo growth inhibition of Ia+ lymphomas in SJL mice treated with I-As-reactive monoclonal antibody.
Alisauskas RM; Ponzio NM
Immunopharmacology; 1986 Aug; 12(1):1-9. PubMed ID: 2428770
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
Ohnishi K; Bonavida B
J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
[TBL] [Abstract][Full Text] [Related]
3. Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes.
Wilbur SM; Bonavida B
J Exp Med; 1981 Mar; 153(3):501-13. PubMed ID: 6166700
[TBL] [Abstract][Full Text] [Related]
4. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
Ohnishi K; Bonavida B
J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
[TBL] [Abstract][Full Text] [Related]
5. T-helper-cell-specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J mice.
Alisauskas RM; Ponzio NM
Cell Immunol; 1989 Apr; 119(2):286-303. PubMed ID: 2467748
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IA positive reticulum cell sarcoma tumor cell growth in syngeneic SJL/J mice by passive administration of monoclonal anti-IA antibody.
Sakano T; Bonavida B
Cancer Res; 1986 Jul; 46(7):3245-8. PubMed ID: 3518916
[TBL] [Abstract][Full Text] [Related]
7. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
[TBL] [Abstract][Full Text] [Related]
8. Ia-restricted interaction between normal lymphoid cells and SJL lymphoma (RCS) leading to lymphokine production. I. Enhancement and suppression of antibody formation to TI antigens by supernatants and cells from cocultures of RCS and lymphoid cells.
Hayama T; Nagler C; Umetsu DT; Chapman-Alexander J; Thorbecke GJ
Cell Immunol; 1983 Jul; 79(1):134-49. PubMed ID: 6222793
[TBL] [Abstract][Full Text] [Related]
9. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
Wilbur SM; Marelli O; Bonavida B
Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
[TBL] [Abstract][Full Text] [Related]
10. IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse.
Lin TZ; Fernandes H; Yauch R; Ponzio NM; Raveche E
Clin Immunol Immunopathol; 1992 Oct; 65(1):10-22. PubMed ID: 1382908
[TBL] [Abstract][Full Text] [Related]
11. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
Katz JD; Lebow LT; Bonavida B
J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
[TBL] [Abstract][Full Text] [Related]
12. I-E expression does not by itself influence growth of or T cell unresponsiveness to SJL lymphomas.
Tsiagbe VK; Rabinowitz JL; Thorbecke GJ
Cell Immunol; 1991 Sep; 136(2):329-39. PubMed ID: 1831403
[TBL] [Abstract][Full Text] [Related]
13. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
Ohnishi K; Bonavida B
J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
[TBL] [Abstract][Full Text] [Related]
14. Influence of T-helper cell specific monoclonal antibody on progressive growth of B-cell lymphomas in SJL/J mice: correlation of acute treatment dosage with tumor dormancy or complete remission in long-term survivors.
Alisauskas RM; Friedman CA; Ponzio NM
Cancer Commun; 1990; 2(1):33-43. PubMed ID: 2142432
[TBL] [Abstract][Full Text] [Related]
15. The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
Katz JD; Ohnishi K; Lebow LT; Bonavida B
J Exp Med; 1988 Nov; 168(5):1553-62. PubMed ID: 2460577
[TBL] [Abstract][Full Text] [Related]
16. Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
DeKruyff RH; Brown PH; Thorbecke GJ; Ponzio NM
J Immunol; 1985 Nov; 135(5):3581-6. PubMed ID: 2413126
[TBL] [Abstract][Full Text] [Related]
17. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon.
Ponzio NM; Hayama T; Nagler C; Katz IR; Hoffmann MK; Gilbert K; Vilcek J; Thorbecke GJ
J Natl Cancer Inst; 1984 Feb; 72(2):311-20. PubMed ID: 6420599
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice.
Wajchman J; Simmons WJ; Klein A; Koneru M; Ponzio NM
Leuk Res; 2002 Jun; 26(6):577-90. PubMed ID: 12007506
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
Bonavida B; Roman JM; Hutchinson IV
Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
[TBL] [Abstract][Full Text] [Related]
20. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
